AKT1 and Insulin resistance: Furthermore, CYP2J3 overexpression significantly improved insulin resistance, at least in part through eNOS, IRS-1, and PI3K/AKT signaling pathways, as well as adenosine monophosphate-activated protein kinase (AMPK) signaling pathways in liver, muscle, heart, and kidney[9].